FDA — authorised 16 February 2001
- Application: NDA050781
- Marketing authorisation holder: ORAPHARMA
- Status: supplemented
FDA authorised Arestin on 16 February 2001
Yes. FDA authorised it on 16 February 2001; FDA has authorised it.
ORAPHARMA holds the US marketing authorisation.